INS and acromegaly: However, pegvisomant exerts a favorable effect on carbohydrate metabolism in patients with acromegaly, including those with diabetes, by decreasing fasting glucose and HbA1c levels, as well as improving insulin sensitivity, which is beneficial for patients both with and without diabetes [101,102,103,104,105].